Samsung Biologics’ 2026 growth strategy on track with full plant utilization

Monday, August 3, 2026 (Greg Slabodkin)View original

The CDMO reported stable manufacturing operations across Plants 1 through 4 in South Korea, as the company expands its global footprint.

Read the full article on the original site.